<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="63885">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02062437</url>
  </required_header>
  <id_info>
    <org_study_id>1301-T-CERAM-R</org_study_id>
    <nct_id>NCT02062437</nct_id>
  </id_info>
  <brief_title>Clinical and Radiological Results of Total Hip Arthroplasty Using a Ceramic Friction Pair</brief_title>
  <acronym>CERAM</acronym>
  <official_title>Multicentric Observational Study Evaluating Clinical and Radiological Results of a Total Hip Arthroplasty Using a Ceramic Friction Pair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tornier</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tornier</source>
  <oversight_info>
    <authority>France: Ministère de l'Enseignement supérieur et de la Recherche</authority>
    <authority>France: The Commission nationale de l’informatique et des libertés</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess safety and general performance of total hip arthroplasty,
      composed of a Meije Duo® femoral stem associated with a Dynacup® cup, and using the friction
      pair Biolox® Delta Ceramic.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>Adverse events</measure>
    <time_frame>2-year follow-up visit</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Surgical incidents.
Post-operative complications.
Failure and revisions analysis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>General performance: Mobility</measure>
    <time_frame>2-year Follow-up visit</time_frame>
    <safety_issue>No</safety_issue>
    <description>Mobility is assessed by the measurement of the degree of amplitude of: extension, flexion, abduction, adduction, external rotation and internal rotation of the hip.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>General performance: objective clinical score (PMA)</measure>
    <time_frame>2-year Follow-up visit</time_frame>
    <safety_issue>No</safety_issue>
    <description>Postel Merle d'Aubigne (PMA) rating contains three items; pain, function and hip mobility; each noted 6 points (18 is the best score).</description>
  </other_outcome>
  <other_outcome>
    <measure>General performance: Radiological assessment.</measure>
    <time_frame>2-year Follow-up visit</time_frame>
    <safety_issue>No</safety_issue>
    <description>Radiological assessment is based on :
Cup radiological signs.
Stem radiological signs.
Ossifications</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">132</enrollment>
  <condition>Hip Replacement</condition>
  <condition>Primary, Secondary or Post-traumatic Osteoarthrosis</condition>
  <condition>Femur Head Necrosis</condition>
  <condition>Congenital Dislocations</condition>
  <arm_group>
    <arm_group_label>Total hip replacement using a ceramic friction pair</arm_group_label>
    <description>Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Cohort of European patients with a primary total hip replacement using a ceramic friction
        pair including Meije Duo® stem associated with a Dynacup® cup.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female patient implanted with a primary total hip replacement using a ceramic
             friction pair including Meije Duo® stem associated with a Dynacup® cup.

          -  Aged of more than 18 years at the time of the surgery.

          -  Patient with a follow-up of at least 2 years after surgery based on a consecutive and
             exhaustive series of patients operated within the inclusion period.

          -  Able to understand information to participate to the study.

        Exclusion Criteria:

          -  Patient having a tumoral pathology.

          -  Patient having expressed opposition to the study participation.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 12, 2014</lastchanged_date>
  <firstreceived_date>February 12, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Arthroplasty</keyword>
  <keyword>Hip Replacement</keyword>
  <keyword>Ceramic</keyword>
  <keyword>Acetabular cup</keyword>
  <keyword>Femoral stem</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dislocations</mesh_term>
    <mesh_term>Femur Head Necrosis</mesh_term>
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Necrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
